This content is only available within our institutional offering.
06 Dec 2018
LIBERUM: Strategy & Stock Selection - Sinners – 2018 Edition
AstraZeneca PLC (AZN:LON), 10,689 | BAE Systems plc (BA:LON), 1,352 | Rolls-Royce Holdings plc (RR:LON), 427 | Marks and Spencer Group plc (MKS:LON), 265 | Melrose Industries PLC (MRO:LON), 674 | GSK plc (GSK:LON), 1,709 | Johnson Matthey Plc (JMAT:LON), 1,779 | Imperial Brands PLC (IMB:LON), 1,775 | Pearson PLC (PSON:LON), 1,044 | Reckitt Benckiser Group plc (RKT:LON), 4,521
Sign in
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
This content is only available to commercial clients. Sign in if you have access or contact support@research-tree.com to set up a commercial account
LIBERUM: Strategy & Stock Selection - Sinners – 2018 Edition
AstraZeneca PLC (AZN:LON), 10,689 | BAE Systems plc (BA:LON), 1,352 | Rolls-Royce Holdings plc (RR:LON), 427 | Marks and Spencer Group plc (MKS:LON), 265 | Melrose Industries PLC (MRO:LON), 674 | GSK plc (GSK:LON), 1,709 | Johnson Matthey Plc (JMAT:LON), 1,779 | Imperial Brands PLC (IMB:LON), 1,775 | Pearson PLC (PSON:LON), 1,044 | Reckitt Benckiser Group plc (RKT:LON), 4,521
- Published:
06 Dec 2018 -
Author:
Andrew Bryant -
Pages:
38